Brief: Adocia Announces Clinical Trial Evaluating BioChaperone Lispro

Adocia SA

03/01/2019 17:11

Jan 3 (Reuters) - ADOCIA SA  ADOC.PA :
    * ADOCIA ANNOUNCES A CLINICAL TRIAL EVALUATING BIOCHAPERONE®
LISPRO AND OTHER RAPID-ACTING INSULIN ANALOGS USING ILETTM
BIONIC PANCREAS
    * FIRST TRIAL TO TEST ULTRA-RAPID INSULIN BIOCHAPERONE
LISPRO WITH
AUTOMATED INSULIN DELIVERY
    * USING INSULIN-ONLY CONFIGURATION OF ILET BIONIC PANCREAS
SYSTEM,
THIS TRIAL WILL INVESTIGATE EFFECT OF DIFFERENT PHARMACOKINETIC
CHARACTERISTICS OF INSULIN ASPART, INSULIN LISPRO, AND
ULTRA-RAPID BIOCHAPERONE LISPRO ON GLYCEMIC CONTROL

Source text for Eikon:  ID:nBw6YXbzNa 
Further company coverage:  ADOC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))